Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MOH · against 159 other Healthcare companies of similar size
Ranked #93 of 160 · scores higher than 41% of peers
Bars: peers in each 10-point band of the valuation score28 peers with a valuation score of 40–49, including MOH · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | MOH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 159 reported | 0.0% | 2.6% | 24% | 30% | |
| EBITDA yieldHigher is better · 159 reported | 6.6% | 4.7% | 68% | 50% | |
| Free cash flow yieldHigher is better · 94 reported | 2.5% | 2.4% | 52% | 20% | |
| Book yieldHigher is better · 158 reported | 38.6% | 18.7% | 75% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 2 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 3 | 10.4B USD | 96 | 64 | |
| 4 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 4 | 21.5B USD | 95 | 60 | |
| 89 | 558.5B INR (≈$6.7B) | 50 | 47 | |
| 89 | 521.3B INR (≈$6.3B) | 50 | 69 | |
| 89 | 9.0B USD | 50 | 78 | |
| 89 | 6.3B USD | 50 | 78 | |
| 93 | 10.8B USD | 49 | 35 | |
| 93 | 32.3B AUD (≈$21.3B) | 49 | 55 | |
| 93 | 15.8B EUR (≈$17.4B) | 49 | 47 | |
| 96 | 7.2B USD | 48 | 43 | |
| 96 | 12.3B USD | 48 | 35 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score